Extracellular influences on tumour angiogenesis in the aged host

British Journal of Cancer

Volumn 98, Issue 2, 2008, Pages 250-255

  Sprenger, C C ^a,b   Plymate, S R ^b,c   Reed, M J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Angiogenesis; Growth factors; Matrix metalloproteinases; Microenvironment; Prostate cancer; Senescence

Indexed keywords

ANDROGEN; CELL PROTEIN; GROWTH FACTOR; MATRIX METALLOPROTEINASE;

AGED; AGING; ANDROGEN BLOOD LEVEL; ANGIOGENESIS; CARCINOGENESIS; DISEASE COURSE; ENZYME BLOOD LEVEL; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; NUTRIENT SUPPLY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SHORT SURVEY; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; ANDROGENS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; EXTRACELLULAR SPACE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS;

EID: 38549113150     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604144     Document Type: Short Survey

References (52)

1. Ashcroft G, Dodsworth J, van Boxtel E, Tarnuzzer R, Horan M, Schultz G, Ferguson M (1997) Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nat Med 3: 1209-1215
2. Bavik C, Coleman I, Dean J, Knudsen B, Plymate S, Nelson P (2006) The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 66: 794-802
3. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2: 737-744
4. Bissell M, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1: 46-54
5. Bonnet P, Reiter E, Bruyninx M, Sente B, Dombrowicz D, de Leval J, Closset J, Hennen G (1993) Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J Clin Endocrinol Metab 77: 1203-1208
6. Campisi J (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120: 513-522
7. Chung L, Baseman A, Assikis V, Zhau H (2005) Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urology 173: 10-20
8. Colombel M, Filleur S, Fournier P, Merle C, Guglielmi J, Courtin A, Degeorges A, Serre CM, Bouvier R, Clezardin P, Cabon F (2005) Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate. Cancer Res 65: 300-308
9. DeHahn K, Gonzales M, Gonzalez A, Hopkinson S, Chandel N, Brunelle J, Jones J (2004) The a4 laminin subunit regulates endothelial cell survival. Exp Cell Res 294: 281-289
10. Duque J, Loughlin K, Adam R, Kantoff P, Zurakowski D, Freeman M (1999) Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urology 54: 523-527
11. Elola M, Wolfenstein-Todel C, Troncoso M, Vasta G, Rabinovich G (2007) Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci 64: 1679-1700
12. Ershler WB (1986) Why tumors grow more slowly in old people. J Natl Cancer Inst 77: 837-839
13. Fontana A, Filleur S, Guglielmi J, Frappart L, Bruno-Bossio G, Boissier S, Cabon F, Clezardin P (2005) Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo. Int J Cancer 116: 689-691
14. Framson P, Sage E (2004) SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 92: 679-690
15. Fujita M, Khazenzon N, Bose S, Sekiguchi K, Sasaki T, Carter W, Ljubimov A, Black K, Ljubimova J (2005) Overexpression of β1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. Breast Cancer Res 7: R411-R421
16. Fujita M, Khazenzon N, Ljubimov A, Lee B-S, Virtanen I, Holler E, Black K, Ljubimova J (2006) Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis. Angiogenesis 9: 183-191
17. Gazoti Debessa C, Mesiano Maifrino L, Rodrigues de Souza R (2001) Age-related changes of the collagen network of the human heart. Mech Ageing Dev 122: 1049-1058
18. Goel H, Fornaro M, Moro L, Teider N, Rhim J, King M, Languino L (2004) Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrins. J Cell Biol 166: 407-418
19. Grzmil M, Hemmerlein B, Thelen P, Schweyer S, Burfeind P (2004) Blockade of the type 1 IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, upregulates IGF binding protein-3, and suppresses MMP-2 expression. J Pathol 202: 50-59
20. Hornebeck W, Emonard H, Monboisee J-C, Bellon G (2002) Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 12: 231-241
21. Isayeva T, Chanda D, Kallman L, Eltoum I-E, Ponnazhagan S (2007) Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model. Cancer Res 67: 5789-5797
22. Kaplan P, Mohan S, Cohen P, Foster B, Greenberg N (1999) The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res 59: 2203-2209
23. Kaplan R, Rafii S, Lyden D (2006) Preparing the 'soil': the premetastatic niche. Cancer Res 66: 11089-11093
24. Kreisle R, Stebler B, Ershler W (1990) Effect of host age on tumor-associated angiogenesis in mice. J Natl Canc Inst 82: 44-47
25. Kupprion C, Motamed K, Sage E (1998) SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273: 29635-29640
26. Langley R, Fidler I (2007) Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 28: 297-321
27. London C, Sekhon H, Arora V, Stein D, Iversen P, Devi G (2003) A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity. Cancer Gene Ther 10: 823-832
28. Luo J, Dunn T, Ewing C, Sauvageot J, Chen Y, Trent J, Isaacs W (2002) Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis. Prostate 51: 189-200
29. Mancini A, Di Battista JA (2006) Transcriptional regulation of matrix metalloprotease gene expression in health and disease. Front Biosci 11: 423-446
30. Miele C, Rochford J, Filippa N, Giorgetti-Peraldi S, Van Obberghen E (2000) Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem 275: 21695-21702
31. Mostaghel E, Page S, Lin D, Fazli L, Coleman I, True L, Knudsen B, Hess D, Nelson C, Matsumoto A, Bremner W, Gleave M, Nelson P (2007) Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res 67: 5033-5041
32. Naumov G, Bender E, Zurakowski D, Kang S, Sampson D, Flynn E, Watnick R, Straume O, Akslen L, Folkman J, Almog N (2006) A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst 98: 316-325
33. Nelson C, Bissell M (2006) Of extracellular matrix, scaffold, and signaling: tissue architecture regulates development, homeostasis, and cancer. Ann Rev Cell Dev Biol 22: 287-309
34. Patarroyo M, Tryggvason K, Virtanen I (2002) Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol 12: 197-207
35. Peyromaure M, Goulvestre C, Fulla Y, Grabar S, Debre B, Dihn-Xuan A (2005) Serum levels of vascular endothelial growth factor in patients undergoing prostate biopsy for suspicion of prostate cancer. Urology 66: 687-691
36. Phillips JA, Bonassar LJ (2005) Matrix metalloproteinase activity synergizes with alpha2beta1 integrins to enhance collagen remodeling. Exp Cell Res 310: 79-87
37. Pili R, Guo Y, Chang J, Nakanishi H, Martin GR, Passaniti A (1994) Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Cancer Inst 86: 1303-1314
38. Reed M, Bradshaw A, Shaw M, Sadoun E, Han N, Ferara N, Funk S, Puolakkainen P, Sage E (2005) Enchanced angiogenesis characteristic of SPARC-null mice disappears with age. J Cell Physiol 204: 800-807
39. Reed M, Ferara N, Vernon R (2001) Impaired migration, integrin function, and actin cytoskeletal organization in dermal fibroblasts from a subset of aged human donors. Mech Ageing Dev 122: 1203-1220
40. Reed M, Karres N, Eyman D, Cruz A, Brekken R, Plymate S (2007) The effects of aging on tumor growth and angiogenesis are tumor-cell dependent. Int J Cancer 120: 753-760
41. Reed MJ, Corsa AC, Kudravi SA, McCormick RS, Arthur WT (2000) A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells. J Cell Biochem 77: 116-126
42. Rivard A, Berthou-Soulie L, Principe N, Kearney M, Curry C, Branellec D, Semenza GL, Isner JM (2000) Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 275: 29643-29647
43. Rivard A, Fabre J, Silver M, Chen D, Murohara T, Kearney M, Magner M, Ashara T, Isner JM (1999) Aged-dependent impairment of angiogenesis. Circ 99: 111-120
44. Sage E, Reed M, Funk S, Truong T, Steadele M, Puolakkainen P, Maurice D, Bassuk J (2003) Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J Biol Chem 278: 37849-37857
45. Stuelten CH, DaCosta Byfield S, Arany PR, Karpova TS, Stetler-Stevenson WG, Roberts AB (2005) Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta. J Cell Sci 118: 2143- 2153
46. Stupack D, Cheresh D (2002) ECM remodeling regulates angiogenesis: endothelial integrins look for new ligands. Sci STKE 2002: pe7, doi:10.1126/stke.2002.119.pe7
47. Tan T, Coussens L (2007) Humoral immunity, inflammation and cancer. Curr Opin Immunol 19: 209-216
48. Thum T, Hoeber S, Froese S, Klink I, Stichtenoth D, Galuppo P, Jakob M, Tsikas D, Anker S, Poole-Wilson P, Borlak J, Ertl G, Bauersachs J (2007) Age-dependent impairment of endothelial progenitor cells is corrected by growth hormone mediated increase of insulin-like growth factor-1. Circ Res 100: 434-443
49. Wood M, Fudge K, Mohler JL, Frost AR, Garcia F, Wang M, Stearns ME (1997) In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin Exp Metastasis 15: 246-258
50. Zhang D, Bar-Eli M, Meloche S, Broude E (2004) Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the PI 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. J Biol Chem 279: 19683-19690
51. Zhang H, Pan K-H, Cohen S (2003) Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of upregulated chromosomal loci. Proc Natl Acad Sci USA 100: 3251-3256
52. Zhou Z, Doi M, Wang J, Cao R, Liu B, Chan K, Kortesmaa J, Sorokin L, Cao Y, Tryggvason K (2004) Deletion of laminin-8 results in increased tumor neovascularization and metastasis in mice. Cancer Res 64: 4059-4063